皇冠体育app

/ Comment

Yin Weidong, Chairman and CEO of Sinovac Biotech Ltd

皇冠体育app Daily | Updated: 2010-11-22 07:48

Yin Weidong, Chairman and CEO of Sinovac Biotech Ltd

Some 20 years ago, Yin Weidong decided he had to do something about the problem of 皇冠体育app having to rely on imported vaccines and his effort paid off.

In 1999, Yin invented the first inactivated (with organisms that are dead) hepatitis A (HA) vaccine in 皇冠体育app, then continued his research in his company, Sinovac Biotech, now listed on the NASDAQ.

The company has become a Chinese pioneer in inactivated HA, inactivated SARS, pandemic influenza, and Influenza A H1N1 vaccines. In a race against time during the "swine flu" epidemic, Sinovac Biotech was able to prepare an Influenza A H1N1 vaccine and market it in just 87 days.

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to 皇冠体育app Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online

Registration Number: 130349
FOLLOW US